Table II.

Response rates to questionnaires among surviving patients at all time points from t0 (prior to radiotherapy) to t4 (12 months).

	Patients who responded at each time point (%)
Patient groups	t0	t1	t2	t3	t4
All patients	100	100	78.6	81.5	63.6
Benign	100	100	81.3	87.5	68.8
Malignant	100	100	75.0	72.7	50.0
Meningioma	100	100	90.9	90.9	72.7
GBM	100	100	78.8	62.5	66.7

GBM, glioblastoma multiforme; t0, prior to radiotherapy; t1, following radiotherapy; t2, 3 months after radiotherapy; t3, 6 months after radiotherapy; t4, 12 months after radiotherapy.